Duchenne muscular dystro- phy: an old anesthesia problem revisited. Paediatr Anaesth 2008; 18: 100 - 6Hayes J, Veyckemans F, Bissonnette B: Duchenne muscular dystrophy: An old anesthesia problem revisited. Paediatr Anaesth 2008; 18:100-6...
Duchenne muscular dystrophy is a severe, progressive, muscle-wasting disease that leads to difficulties with movement and, eventually, to the need for assisted ventilation and premature death. The disease is caused by mutations in DMD (encoding dystrophi
Duchenne muscular dystrophy (DMD) is caused by pathogenic variants in the X-linkedDMDgene, leading to an absence of functional dystrophin and continuous muscle damage, beginning from birth1. Impaired motor function can be observed by the age of 3 years and typically progresses to loss of ambul...
Duchenne muscular dystrophy (DMD) is a severe, progressive, muscle-wasting disease, characterized by progressive deterioration of skeletal muscle that caus
请注意:出版商不对作者提供的任何支持信息的内容或功能负责。任何疑问(除了缺少的内容)都应该直接联系文章的相应作者。 Profoundly lower muscle mass and rate of contractile protein synthesis in boys with Duchenne muscular dystrophyThe J...
Share this article WASHINGTON, Aug. 27, 2024 /PRNewswire/ -- Marking a significant milestone in improving the lives of children affected by Duchenne muscular dystrophy (Duchenne), Parent Project Muscular Dystrophy (PPMD) proudly announces that Massachusetts has approved the additio...
director of the Division of Human Development and Disability at the CDC, speaking to you as part of theCDC Expert Commentary serieson Medscape. I'm pleased to speak with you about an important development that will help improve quality of life for people who have Duchenne muscular dystrophy. ...
Duchenne muscular dystrophy (DMD) is characterized by muscle degeneration and progressive weakness. There is considerable inter-patient variability in disease onset and progression, which can confound the results of clinical trials. Here we show that a c
DuchenneMuscularDystrophyisafatalgeneticmutationin aboutoneofevery3,500boys. 杜氏肌萎缩症是一种致死性的基因突变疾病,平均每3500个男孩中就有一个罹患此病。 article.yeeyan.org 3. Thedrug,knownas PTC124, hasalreadyhad encouragingresultsinpatientswithDuchennemusculardystrophyandcysticfibrosis. ...
Dystrophin: the protein product of the duchenne muscular dystrophy locus. Cell. 1987;51(6):919–28. https://doi.org/10.1016/0092-8674(87)90579-4. Article CAS PubMed Google Scholar Tuffery-Giraud S, Béroud C, Leturcq F, Yaou RB, Hamroun D, Michel-Calemard L, et al. Genotype-...